XML 74 R38.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Significant Accounting Policies, Research, Development and Patent Expenses (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Research, Development and Patent Expenses [Abstract]      
Research and development expenses $ 531,000 $ 461,500 $ 411,900
Estimated Amortization Expense [Abstract]      
Non-cash charges related to write-down 1,948 2,226 802
Patents [Member]      
Research, Development and Patent Expenses [Abstract]      
Research and development expenses $ 4,100 4,200 2,600
Estimated useful life 10 years 3 months 18 days    
Cost $ 37,000 34,000  
Accumulated amortization 9,100 8,300  
Estimated Amortization Expense [Abstract]      
2021 2,100    
2022 2,000    
2023 1,900    
2024 1,700    
2025 1,600    
Non-cash charges related to write-down 1,900 2,200 800
Collaborative Agreements [Member]      
Research, Development and Patent Expenses [Abstract]      
Research and development expenses $ 49,800 $ 83,200 $ 58,700